Hunan Cancer Hospital
Clinical trials sponsored by Hunan Cancer Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced breast cancer: drug combo trial launches Results expected Dec 2026 (estimated)
- Personalized navigation may boost cancer screening in high-risk communities Results expected Mar 2027 (estimated)
-
Can a Cholesterol-Lowering injection help lung cancer patients stay on a key treatment?
Disease control Not yet recruitingThis study tests whether recakimab, an injectable drug that lowers cholesterol, can safely reduce high cholesterol caused by the lung cancer medication lorlatinib. The trial enrolls about 29 adults with advanced ALK-positive non-small cell lung cancer who developed high cholester…
Phase 4 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple-Drug attack aims to shrink cervical cancer tumors
Disease control Not yet recruitingThis Phase 2 trial tests a combination of three drugs—camrelizumab, famitinib, and standard chemotherapy—in 54 women with recurrent or metastatic cervical cancer that cannot be treated with surgery or radiation. The goal is to see if the combo shrinks tumors and controls the dise…
Phase 2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Not yet recruitingThis early-stage trial tests a drug called sacituzumab govitecan combined with hormone therapy in 12 people with HR-positive, HER2-negative metastatic breast cancer that has worsened after CDK4/6 inhibitor treatment. The main goal is to check safety and side effects, while also l…
Phase 1 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC